NASDAQ: HON
HONEYWELL INTERNATIONAL INCCIK 0000773840 · SIC 3724 · Aircraft Engines & Parts
Mega
Revenue $37.4B
Assets $77.3B
as of Oct 18, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WCN 10-Q) is open in full — no account needed.
8-K
Filed Oct 22, 2026
· Period ending Oct 22, 2026
Summary not yet generated.
10-Q
Filed Oct 22, 2026
· Period ending Sep 30, 2026
Critical
Honeywell's third-quarter net income attributable to Honeywell Technologies fell 63.6% to $664.0M.
7 material changes detected. Sign up free to read the summary.
Partner
Trade HON commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Aug 19, 2026
· Period ending Aug 19, 2026
Summary not yet generated.
10-Q/A
Filed Jul 24, 2026
· Period ending Jun 30, 2026
Disclosure removed
revenue $9.72B, net income $5.68B. Honeywell 10-Q/A corrects backlog table; removes SEC investigation disclosure with no update
4 material changes detected. Sign up free to read the summary.
10-Q
Filed Jul 23, 2026
· Period ending Jun 30, 2026
revenue $9.72B, net income $5.68B. Honeywell completes Aerospace spin-off, books Quantinuum gain as net income surges 262%
6 material changes detected. Sign up free to read the summary.
8-K
Filed Jul 23, 2026
· Period ending Jul 23, 2026
Honeywell reports Q2 results post-Aerospace spin, books $5.1B Quantinuum gain
5 material changes detected. Sign up free to read the summary.
8-K
Filed Jun 29, 2026
· Period ending Jun 25, 2026
Summary not yet generated.
8-K
Filed Jun 15, 2026
· Period ending Jun 15, 2026
Summary not yet generated.
10-Q
Filed Apr 23, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
10-K
Filed Feb 17, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-Q
Filed Oct 23, 2025
· Period ending Sep 30, 2025
Summary not yet generated.
10-Q
Filed Jul 24, 2025
· Period ending Jun 30, 2025
Summary not yet generated.
10-K
Filed Feb 14, 2025
· Period ending Dec 31, 2024
Summary not yet generated.
424B5
Filed Oct 24, 2024
Summary not yet generated.
424B5
Filed Oct 24, 2024
Summary not yet generated.
424B5
Filed Jul 31, 2024
Summary not yet generated.
424B3
Filed Jan 31, 2023
Summary not yet generated.
Latest financial statements
From 10-Q filed Oct 22, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statement of Operations (Unaudited)
(Dollars in millions, except per share amounts)
| Description | Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 |
|---|---|---|---|---|
| Product sales | 3,628 | 3,573 | 10,856 | 10,724 |
| Service sales | 1,366 | 1,356 | 4,148 | 3,979 |
| Net sales | 4,994 | 4,929 | 15,004 | 14,703 |
| Costs, expenses and other | ||||
| Cost of products sold | 2,127 | 2,041 | 6,421 | 6,179 |
| Cost of services sold | 849 | 1,114 | 2,593 | 2,749 |
| Total Cost of products and services sold | 2,976 | 3,155 | 9,014 | 8,928 |
| Research and development expenses | 239 | 268 | 825 | 774 |
| Selling, general and administrative expenses | 1,039 | 1,093 | 3,078 | 3,372 |
| Impairment of assets held for sale | — | — | 311 | 15 |
| Loss on debt extinguishment | — | — | 241 | — |
| Gain on deconsolidation of subsidiary | — | — | (6,629) | — |
| Other (income) expense | (389) | (957) | (301) | (1,124) |
| Interest and other financial charges | 143 | 263 | 579 | 715 |
| Total costs, expenses and other | 4,008 | 3,822 | 7,118 | 12,680 |
| Income from continuing operations before taxes and equity losses | 986 | 1,107 | 7,886 | 2,023 |
| Tax expense | 60 | 153 | 1,378 | 427 |
| Equity loss | 147 | — | 412 | — |
| Net income from continuing operations | 779 | 954 | 6,096 | 1,596 |
| Net (loss) income from discontinued operations | (103) | 905 | 1,061 | 3,299 |
| Net income | 676 | 1,859 | 7,157 | 4,895 |
| Less: Net income (loss) attributable to noncontrolling interest | 12 | 34 | (10) | 51 |
| Net income attributable to Honeywell Technologies | 664 | 1,825 | 7,167 | 4,844 |
| Earnings (loss) per share of common stock—basic: | ||||
| Earnings per share of common stock from continuing operations—basic1 | 2.42 | 3.01 | 19.30 | 5.02 |
| (Loss) earnings per share of common stock from discontinued operations—basic1 | (0.33) | 2.73 | 3.29 | 10.11 |
| Total earnings per share of common stock—basic1 | 2.09 | 5.74 | 22.59 | 15.13 |
| Earnings (loss) per share of common stock—assuming dilution: | ||||
| Earnings per share of common stock from continuing operations—assuming dilution1 | 2.40 | 2.99 | 19.19 | 4.99 |
| Earnings per share of common stock from discontinued operations—assuming dilution1 | (0.32) | 2.72 | 3.27 | 10.05 |
| Total earnings per share of common stock—assuming dilution1 | 2.08 | 5.71 | 22.46 | 15.04 |
Consolidated Balance Sheet (Unaudited)
(Dollars in millions)
| Description | September 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | 5,694 | 12,273 |
| Short-term investments | 492 | 443 |
| Accounts receivable, less allowances of $155 and $167, respectively | 5,086 | 4,429 |
| Inventories | 2,056 | 1,677 |
| Assets held for sale | — | 2,492 |
| Other current assets | 988 | 841 |
| Current assets of discontinued operations | — | 8,232 |
| Total current assets | 14,316 | 30,387 |
| Equity method investments | 7,273 | 195 |
| Long-term receivables and other investments | 1,114 | 1,113 |
| Property, plant and equipment—net | 2,706 | 2,466 |
| Goodwill | 17,561 | 18,054 |
| Other intangible assets—net | 5,442 | 5,161 |
| Deferred income taxes | 199 | 156 |
| Other assets | 4,487 | 4,537 |
| Assets of discontinued operations | — | 11,612 |
| Total assets | 53,098 | 73,681 |
| Liabilities | ||
| Current liabilities | ||
| Accounts payable | 3,592 | 3,434 |
| Commercial paper and other short-term borrowings | 2,424 | 5,893 |
| Current maturities of long-term debt | 3,783 | 1,541 |
| Accrued liabilities | 5,112 | 5,063 |
| Liabilities held for sale | — | 1,198 |
| Current liabilities of discontinued operations | — | 6,285 |
| Total current liabilities | 14,911 | 23,414 |
| Long-term debt | 10,386 | 27,137 |
| Deferred income taxes | 1,561 | 815 |
| Postretirement benefit obligations other than pensions | 80 | 111 |
| Other liabilities | 3,506 | 3,986 |
| Liabilities of discontinued operations | — | 3,188 |
| Shareowners’ Equity | ||
| Capital—common stock issued1 | 479 | 479 |
| —additional paid-in capital1 | 11,133 | 10,636 |
| Common stock held in treasury, at cost | (43,854) | (43,029) |
| Accumulated other comprehensive loss | (4,099) | (5,146) |
| Retained earnings | 58,758 | 50,964 |
| Total Honeywell Technologies shareowners’ equity | 22,417 | 13,904 |
| Noncontrolling interest | 237 | 1,126 |
| Total shareowners’ equity | 22,654 | 15,030 |
| Total liabilities and shareowners’ equity | 53,098 | 73,681 |
Consolidated Statement of Cash Flows (Unaudited)
(Dollars in millions)
| Description | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Net income | 7,157 | 4,895 |
| Less: Net income from discontinued operations | 1,061 | 3,299 |
| Net income from continuing operations | 6,096 | 1,596 |
| Adjustments to reconcile net income from continuing operations to net cash provided by operating activities | ||
| Depreciation | 215 | 206 |
| Amortization | 483 | 510 |
| Gain on deconsolidation of subsidiary | (6,629) | — |
| Equity loss (income) of affiliated companies | 397 | (14) |
| (Gain) loss on sale of non-strategic businesses and assets | (351) | 29 |
| Impairment of assets held for sale | 311 | 15 |
| Loss on debt extinguishment | 241 | — |
| Repositioning and other charges | 133 | (516) |
| Net payments for repositioning and other charges | (119) | (307) |
| Resideo indemnification and reimbursement agreement termination payment | — | 1,590 |
| Pension and other postretirement income | (268) | (164) |
| Pension and other postretirement benefit payments | (6) | (13) |
| Stock compensation expense | 182 | 115 |
| Deferred income taxes | 687 | (248) |
| Other | (2) | (362) |
| Changes in assets and liabilities, net of the effects of acquisitions and divestitures: | ||
| Accounts receivable | (546) | (344) |
| Inventories | (50) | (297) |
| Other current assets | (206) | (168) |
| Accounts payable | 44 | 376 |
| Accrued liabilities | 567 | 510 |
| Income taxes | (247) | 96 |
| Net cash provided by operating activities from continuing operations | 932 | 2,610 |
| Net cash (used for) provided by operating activities discontinued operations | (189) | 2,594 |
| Net cash provided by operating activities | 743 | 5,204 |
| Cash flows from investing activities | ||
| Capital expenditures | (369) | (375) |
| Increase in investments | (771) | (1,064) |
| Decrease in investments | 728 | 1,047 |
| Receipts (payments) from settlements of derivative contracts | 123 | (403) |
| Deconsolidation of subsidiary cash | (623) | — |
| Cash paid for acquisitions, net of cash acquired | (1,763) | (2,201) |
| Proceeds from sale of business, net of cash transferred | 1,454 | 1,157 |
| Net cash used for investing activities from continuing operations | (1,221) | (1,839) |
| Net cash used for investing activities from discontinued operations | (252) | (529) |
| Net cash used for investing activities | (1,473) | (2,368) |
| Cash flows from financing activities | ||
| Proceeds from issuance of commercial paper and other short-term borrowings | 12,413 | 19,171 |
| Payments of commercial paper and other short-term borrowings | (15,882) | (16,711) |
| Proceeds from issuance of common stock | 246 | 140 |
| Proceeds from issuance of long-term debt | — | 4,035 |
| Payments of long-term debt | (14,688) | (1,555) |
| Repurchases of common stock | (1,000) | (3,704) |
| Cash dividends paid | (1,816) | (2,214) |
| Pre-separation funding | 15,835 | — |
| Spin-off cash | (1,000) | — |
| Other | (125) | 198 |
| Net cash used for financing activities | (6,017) | (640) |
| Effect of foreign exchange rate changes on cash and cash equivalents | (46) | 167 |
| Net (decrease) increase in cash and cash equivalents | (6,793) | 2,363 |
| Cash and cash equivalents at beginning of period | 12,487 | 10,567 |
| Cash and cash equivalents at end of period | 5,694 | 12,930 |
Amounts as printed on the EDGAR/iXBRL face — (Dollars in millions, except per share amounts); (Dollars in millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗